Spero Therapeutics Inc (SPRO)

Spero Therapeutics (SPRO) Stock Price & Analysis


SPRO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.68 - $3.18
Previous Close$1.82
Average Volume (3M)558.50K
Market Cap
Enterprise Value$5.89M
Total Cash (Recent Filing)$96.25M
Total Debt (Recent Filing)$6.47M
Price to Earnings (P/E)-2.0
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.90
Shares Outstanding52,571,813
10 Day Avg. Volume246,331
30 Day Avg. Volume558,503
Standard Deviation0.29
Financial Highlights & Ratios
Price to Book (P/B)1.67
Price to Sales (P/S)46.24
Price to Cash Flow (P/CF)-1.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.12
Enterprise Value/Gross Profit0.11
Enterprise Value/Ebitda-0.21
Price Target Upside238.98% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Spero Therapeutics Inc’s price range in the past 12 months?
Spero Therapeutics Inc lowest stock price was $0.68 and its highest was $3.18 in the past 12 months.
    What is Spero Therapeutics Inc’s market cap?
    Currently, no data Available
    When is Spero Therapeutics Inc’s upcoming earnings report date?
    Spero Therapeutics Inc’s upcoming earnings report date is Aug 10, 2023 which is in 66 days.
      How were Spero Therapeutics Inc’s earnings last quarter?
      Spero Therapeutics Inc released its earnings results on May 11, 2023. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.333 by $0.083.
        Is Spero Therapeutics Inc overvalued?
        According to Wall Street analysts Spero Therapeutics Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Spero Therapeutics Inc pay dividends?
          Spero Therapeutics Inc does not currently pay dividends.
          What is Spero Therapeutics Inc’s EPS estimate?
          Spero Therapeutics Inc’s EPS estimate is -$0.39.
            How many shares outstanding does Spero Therapeutics Inc have?
            Spero Therapeutics Inc has 52,571,810 shares outstanding.
              What happened to Spero Therapeutics Inc’s price movement after its last earnings report?
              Spero Therapeutics Inc reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.333. Following the earnings report the stock price went down -3.646%.
                Which hedge fund is a major shareholder of Spero Therapeutics Inc?
                Currently, no hedge funds are holding shares in SPRO


                Spero Therapeutics Stock Smart Score

                The Spero Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Spero Therapeutics Inc

                Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant, or MDR, bacterial infections. Its pipeline product candidates include SPR994, SPR741, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.


                Top 5 ETFs holding SPRO

                Market Value
                Smart Score
                Vanguard Total Stock Market ETF
                iShares Core S&P Total U.S. Stock Market ETF
                Up to five ETFs with an Outperform Smart Score that hold SPRO. The ETFs are listed according to market value of SPRO within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                vTv Therapeutics
                Kala Pharmaceuticals
                Xeris Pharmaceuticals
                Daré Bioscience

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis